Tae Hata

4PUBLICATIONS

26CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (4)

Sort by Publication Date:

|Sep 11, 2026

Osimertinib vs. erlotinib combined with an angiogenesis inhibitor in EGFR-mutated non-small cell lung cancer with malignant pleural effusion: a retrospective cohort study.

|Jul 10, 2025

Chemoimmunotherapy Outcomes and Prognostic Factors in Patients with Advanced, Low PD-L1-Expressing Non-Small Cell Lung Cancer.

Tae Hata, Tadaaki Yamada, Yasuhiro Goto

|May 19, 2025

Impact of immune-related adverse events on clinical outcomes in patients with advanced non-small cell lung cancer with low PD-L1 expression, focusing on pneumonitis: a multicenter retrospective study in Japan.

Shiho Goda, Tadaaki Yamada, Kenji Morimoto

|Mar 03, 2023

Exploratory analysis of immunochemotherapy compared to chemotherapy after EGFR-TKI in non-small cell lung cancer patients with EGFR mutation: A multicenter retrospective study.

Tae Hata, Chikara Sakaguchi, Keita Hirano

Pageof 1

Frequent Collaborators

4 joint publications

Tadaaki Yamada

2 joint publications

Akihiro Yoshimura

2 joint publications

Hirokazu Taniguchi

2 joint publications

Keiko Tanimura

2 joint publications

Yasuhiro Goto

2 joint publications

Yoshiki Negi

2 joint publications

Satoshi Watanabe

2 joint publications

Naoki Furuya

2 joint publications

Tatsuki Ikoma

2 joint publications

Akira Nakao

Frequent Collaborators

4 joint publications

Tadaaki Yamada

2 joint publications

Akihiro Yoshimura

2 joint publications

Hirokazu Taniguchi

2 joint publications

Keiko Tanimura